Michael J. Fisher

faculty photo
Associate Professor of Pediatrics at the Children's Hospital of Philadelphia
Attending Physician, Center for Childhood Cancer Research and Division of Oncology, Children's Hospital of Philadelphia
Member, Cancer Center, University of Pennsylvania
Director, Neuro-Oncology Fellowship Program, Children’s Hospital of Philadelphia
Director, Neurofibromatosis Program, Children’s Hospital of Philadelphia
Chief, Neuro-Oncology Section, Division of Oncology, Children’s Hospital of Philadelphia
Department: Pediatrics

Contact information
Center for Childhood Cancer Research and Division of Oncology
The Children’s Hospital of Philadelphia
Colket Translational Research Building - 10th Floor
3501 Civic Center Blvd
Philadelphia, PA 19104
Office: (215)590-2800

Eberhard-Karls Universitaet, Tubingen, Germany, 1987.
B.A. (Psychology, Summa cum Laude)
Amherst College, 1989.
Harvard Medical School (cum Laude), 1994.
Permanent link

Description of Itmat Expertise

Dr. Fisher is interested in the management of brain tumors and tumors related to neurofibromatosis type 1 and in new imaging modalities for evaluation of plexiform neurofibromas and brain tumors.

Selected Publications

de Blank PMK, Fisher MJ, Gittleman H, Barnholtz-Sloan JS, Badve C, Berman JI: Validation of an Automated Tractography Method for the Optic Radiations as a Biomarker of Visual Acuity in Neurofibromatosis-associated Optic Pathway Glioma. Experimental Neurology 299(pt B): 308-316, 2018.

Mahdi J, Shah AC, Sato A, Morris SM, McKinstry RC, Listernick R, Packer RJ, Fisher MJ, Gutmann DH: A Multi-Institutional Study of Brainstem Gliomas in Children with Neurofibromatosis type 1. Neurology 88(16): 1584-1589, Dec 2017.

Avery RA, Katowitz JA, Fisher MJ, Heidary G, Dombi E, Packer RJ, Widemann BC, on behalf of the OPPN Working Group : Orbital/Peri-Orbital Plexiform Neurofibromas in Children with Neurofibromatosis type 1: Multi-disciplinary Recommendations for Care. Ophthalmology 124(1): 123-132, Jan 2017.

Dombi E, Baldwin A, Marcus LJ, Fisher MJ, Weiss B, Kim A, Whitcomb P, Martin S, Aschbacher-Smith LE, Rizvi TA, Wu J, Ershler R, Wolters P, Therrien J, Glod J, Belasco JB, Schorry E, Brofferio A, Starosta AJ, Gillespie A, Doyle AL, Ratner N, Widemann BC: Activity of Selumetinib in Neurofibromatosis Type 1-Related Plexiform Neurofibromas. N Engl J Med 375(26): 2550-2560, Dec 2016.

Payne JM, Barton B, Ullrich NJ, Cantor A, Hearps SJC, Cutter G, Rosser T, Walsh KS, Gioia GA, Wolters PL, Tonsgard J, Schorry E, Viskochil D, Klesse L, Fisher M, Gutmann DH, Silva AJ, Hunter SJ, Rey-Casserly C, Cantor NL, Byars AW, Stavinoha PL, Ackerson JD, Armstrong CL, Isenberg J, O’Neil SH, Packer RJ, Korf B, Acosta MT, North KN, : A randomized placebo-controlled study of lovastatin in children with neurofibromatosis type 1. Neurology 87(24): 2575-2584, Dec 2016.

McCurdy MD, Turner EM, Barakat LP, Hobbie WL, Deatrick JA, Paltin I, Fisher MJ, Hocking MC: Discrepancies among Measures of Executive Functioning in a Subsample of Young Adult Survivors of Childhood Brain Tumor: Associations with Treatment Intensity. Journal of the International Neuropsychological Society 22(9): 900-910, Oct 2016.

Plotkin SR, Davis SD, Robertson KA, Akshintala S, Allen JL, Fisher MJ, Blakeley J, Widemann B, Ferner RE, Marcus CL: Sleep and Pulmonary Outcomes for Clinical Trials of Airway Plexiform Neurofibromas in NF1. Neurology 87 (Suppl 1): S13–S20, Aug 2016.

Armstrong CL, Fisher MJ, Li Y, Lustig RA, Belasco JB, Minturn JE, Cole KA, Hill-Kayser CE, Batra S, Phillips PC : Neuroplastic Response following Radiotherapy for Pediatric Brain Tumors: A Pilot Study. International Journal of Radiation Oncology, Biology, Physics 95(3): 991-998, July 2016.

de Blank PMK, Berman JI, Fisher MJ: Systemic Chemotherapy and White Matter Integrity in Tracts Associated with Cognition Among Children with Neurofibromatosis Type 1. Pediatric Blood & Cancer 63(5): 818-824, May 2016.

Levin MH, Armstrong GT, Broad JH, Zimmerman R, Bilaniuk LT, Feygin T, Liu GT, Fisher MJ: Risk of Optic Pathway Glioma in Children with Neurofibromatosis Type 1 and Optic Nerve Tortuosity or Nerve Sheath Thickening. Brit J Ophthalmol 100(4): 510-514, April 2016.

back to top
Last updated: 02/07/2018
The Trustees of the University of Pennsylvania